AmideBio

US-based biotechnology company (Louisville, CO) specializing in novel peptide drug candidates targeting metabolic disease. Leverages in-silico design and proprietary peptide synthesis. Offers custom peptide synthesis services and catalog peptides. Provides high purity, low-cost peptide solutions for pharmaceutical and biotech customers. True CDMO/drug discovery company.

AmideBio is listed as a CDMO in the peptide supply chain, serving North America markets from USA (Colorado). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.